Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant-Reference-Cited by-同舟云学术

Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant

Published:2021-05 Issue:5 Volume:11 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer J.

Author:

Pabon Cindy M.^ORCID,Li Zhiguo,Hennig Therese,de Castro Carlos,Neff Jadee L.^ORCID,Horwitz Mitchell E.^ORCID,LeBlanc Thomas W.,Long Gwynn D.,Lopez Richard D.,Sung Anthony D.,Chao Nelson,Gasparetto Cristina,Sarantopoulos Stefanie,Adams Donna B.,Erba Harry,Rizzieri David A.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/s41408-021-00481-9.pdf

Reference15 articles.

1. Bloomfield, C. D. et al. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res. 58, 4173–4179 (1998).

2. Grimwade, D. et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children’s Leukaemia Working Parties. Blood 92, 2322–33. (1998).

3. Stolzel, F. et al. Early intervention with allogeneic hematopoietic cell transplantation during chemotherapy-induced aplasia in patients with high-risk acute myeloid leukemia. Leukemia 27, 2068–2072 (2013).

4. Vu, K. et al. Hematologic recovery after pretransplant chemotherapy does not influence survival after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients. Biol. Blood Marrow Transplant 21, 1425–1430 (2015).

5. Network NCC. Acute Myeloid Leukemia (Version 3.2020). https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf (2020).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maintenance Therapy in Acute Myeloid Leukemia;American Journal of Clinical Oncology;2024-09-06

2. Characterization of a multidisciplinary team’s role in hospital discharge for patients receiving hypomethylating agents with venetoclax as induction therapy for acute myeloid leukemia;Supportive Care in Cancer;2023-03-21

3. A retrospective comparison of salvage intensive chemotherapy versus venetoclax-combined regimen in patients with relapsed/refractory acute myeloid leukemia (AML);Therapeutic Advances in Hematology;2022-01